Asher Biotherapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Asher Biotherapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors (NCT05653882) | Asher Biotherapeutics, Inc. | 2023-01-04 |
Track Asher Biotherapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.